Folic Acid structure
|
Common Name | Folic Acid | ||
|---|---|---|---|---|
| CAS Number | 59-30-3 | Molecular Weight | 441.397 | |
| Density | 1.6±0.1 g/cm3 | Boiling Point | N/A | |
| Molecular Formula | C19H19N7O6 | Melting Point | 250 °C | |
| MSDS | Chinese USA | Flash Point | N/A | |
Use of Folic AcidFolic acid(Vitamin M; Vitamin B9) is a B vitamin; is necessary for the production and maintenance of new cells, for DNA synthesis and RNA synthesis. |
| Name | folic acid |
|---|---|
| Synonym | More Synonyms |
| Description | Folic acid(Vitamin M; Vitamin B9) is a B vitamin; is necessary for the production and maintenance of new cells, for DNA synthesis and RNA synthesis. |
|---|---|
| Related Catalog |
| Density | 1.6±0.1 g/cm3 |
|---|---|
| Melting Point | 250 °C |
| Molecular Formula | C19H19N7O6 |
| Molecular Weight | 441.397 |
| Exact Mass | 441.139679 |
| PSA | 213.28000 |
| LogP | -2.48 |
| Index of Refraction | 1.755 |
| Storage condition | 2~8°C |
| Water Solubility | 1.6 mg/L (25 ºC) |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| Hazard Codes | Xn |
| Risk Phrases | R33;R62;R68 |
| Safety Phrases | S24/25 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 1 |
| RTECS | LP5425000 |
| HS Code | 2936290090 |
| Precursor 5 | |
|---|---|
| DownStream 9 | |
| HS Code | 2936290090 |
|---|
|
Small RNAs derived from tRNAs and rRNAs are highly enriched in exosomes from both old and new world Leishmania providing evidence for conserved exosomal RNA Packaging.
BMC Genomics 16 , 151, (2015) Leishmania use exosomes to communicate with their mammalian hosts and these secreted vesicles appear to contribute to pathogenesis by delivering protein virulence factors to macrophages. In other euka... |
|
|
Obesity is associated with increased red blood cell folate despite lower dietary intakes and serum concentrations.
J. Nutr. 145(1) , 79-86, (2015) Folates are essential cofactors in metabolic pathways that facilitate biological methylation and nucleotide synthesis, and therefore have widespread effects on health and diseases. Although obesity is... |
|
|
Graphene-oxide stabilization in electrolyte solutions using hydroxyethyl cellulose for drug delivery application.
Int. J. Pharm. 484(1-2) , 276-82, (2015) Stabilization of graphene oxide (GO) in physiological solution is performed using hydroxyethyl cellulose (HEC) to make the resultant nanohybrid suitable for targeted drug delivery purposes. Short and ... |
| glutamic acid, N-[4-[[(2-amino-4,8-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]- |
| VM/PGA |
| Folbal |
| folic |
| FOLSAN |
| Folic acid |
| Folate |
| N-[p-[[(2-Amino-4-hydroxy-6-pteridinyl)methyl]amino]benzoyl]glutamic Acid |
| EINECS 200-419-0 |
| Folan |
| N-(p-[(2-Amino-4-hydroxypyrimido[4,5-b]pyrazin-6-yl)methylamino]benzoyl)glutamic Acid |
| pteroic acid-glutamate |
| Pteroyglutamic acid |
| Folsav |
| 4-Pteridinol, 2-amino-6-((p-((1,3-dicarboxypropyl)carbamoyl)anilino)methyl)- |
| PGA |
| MFCD00079305 |
| PTEGLU |
| N-(4-{[(2-Amino-4-oxo-4,8-dihydropteridin-6-yl)methyl]amino}benzoyl)glutamic acid |
| 2-[(4-{[(2-Amino-4-oxo-1,4-dihydro-6-pteridinyl)methyl]amino}benzoyl)amino]pentanedioic acid |
| N-(4-{[(2-Amino-4-hydroxypteridin-6-yl)methyl]amino}benzoyl)glutamic acid |
| Aspol |
| N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)glutamic acid |
| Glutamic acid, N-[4-[[(2-amino-4-hydroxy-6-pteridinyl)methyl]amino]benzoyl]- |
| N-(4-{[(2-Amino-4-oxo-1,4-dihydro-6-pteridinyl)methyl]amino}benzoyl)glutamic acid |
| Folicacidhydrate |